Effects of HMG-CoA Reductase Inhibitor [rosuvastatin] on Progression of Carotid Intima-Media Thickness and Arterial Stiffness in Rheumatoid Arthritis
Phase of Trial: Phase II
Latest Information Update: 26 Jan 2011
At a glance
- Drugs Rosuvastatin (Primary)
- Indications Atherosclerosis
- Focus Biomarker; Therapeutic Use
- 26 Jan 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 04 Dec 2007 New trial record.